Back to Catalog
Resilience
resilience
Contract manufacturer for advanced biologics, gene therapy, and cell therapy.
Total Funding
$3.3B
sector:biotech
stage:growth
CDMO
biomanufacturing
gene-therapy
cell-therapy
restructuring-2025
Full Profile Gated
Register as a Qualified Purchaser to access the full profile of Resilience, including financial analysis, competitive landscape, and investment thesis.